Magnesium Muscle Cramps Randomized Trial: What the Evidence Says

Quick Answer

Magnesium Muscle Cramps Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• ,, From a clinical perspective, the conclusion that magnesium is the most plausible translational candidate for TMD myalgia should remain cautious. [Padhi Swarupanjali (2026); evidence level 1]
• A more measured interpretation of translational relevance would also better align the article with current evidence and clinical practice. [Padhi Swarupanjali (2026); evidence level 1]
• Temporomandibular disorders (TMDs) are among the most common causes of chronic orofacial pain, with myalgia of the masticatory muscles being a major.Patients frequently present with persistent aching pain, muscle tenderness, and restricted jaw function, all of which significantly impair quality of life.While existing treatments are mainly symptomatic,emerging evidence suggests a role for electrolyte modulation. [Patil Shankargouda (2026); evidence level 1]
• Notably, a recent randomized controlled trial demonstrated that local magnesium sulphate injection into the masseter muscle significantly reduced pain intensity and improved function in TMD myalgia, providing a direct clinical link between electrolyte biology and orofacial pain.This observation highlights the potential for broader exploration of electrolyte-based interventions in TMD. [Patil Shankargouda (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium muscle cramps randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Padhi Swarupanjali (2026). Comment on “Electrolytes in Muscle Pain: Systematic Review and Meta-Analysis with Implications for TMD”. DOI: 10.1016/j.identj.2026.109599. PMCID: PMC13126004. PMID: 42030752. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13126004/
• Patil Shankargouda (2026). The Role of Electrolytes in Muscle Pain Syndromes: A Systematic Review and Meta-Analysis With Implications for Temporomandibular Disorder. DOI: 10.1016/j.identj.2026.109488. PMCID: PMC12994056. PMID: 41812583. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12994056/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.